2021
Non-steroidal treatment of cardiac sarcoidosis: A systematic review
Gallegos C, Oikonomou EK, Grimshaw A, Gulati M, Young BD, Miller EJ. Non-steroidal treatment of cardiac sarcoidosis: A systematic review. IJC Heart & Vasculature 2021, 34: 100782. PMID: 33997256, PMCID: PMC8105294, DOI: 10.1016/j.ijcha.2021.100782.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNon-steroidal treatmentSteroid-sparing agentCardiac sarcoidosisSafety profileSystematic reviewCases of CSDisease-modifying antirheumatic agentsManagement of CSActive cardiac sarcoidosisAnti-inflammatory managementAverage corticosteroid doseHigher-line treatmentsMaintenance steroid doseFirst-line treatmentSide effect profileSteroid-sparing therapiesInception of databasesLong-term useCorticosteroid doseSteroid doseBiologic DMARDsImmunosuppressive therapyTreatment initiationEffect profileImmunosuppressive agents
2015
Multimodality Imaging of Cardiac Sarcoidosis
Blankstein R, Miller E. Multimodality Imaging of Cardiac Sarcoidosis. 2015, 51-72. DOI: 10.1007/978-3-319-14624-9_7.ChaptersCardiac sarcoidosisCardiac MRIImaging testsHigh negative predictive valueExtra-cardiac diseasePreferred imaging testLate gadolinium enhancementFuture adverse eventsNegative predictive valueActive myocardial inflammationImmunosuppressive therapyCardiac involvementMyocardial inflammationAdverse eventsExcellent prognosisClinical criteriaReliable reference standardGadolinium enhancementSarcoidosisPredictive valueMultimodality imagingPatientsTherapyMRIDiagnosis